INTERSTITIAL LUNG DISEASE DUE TO CONNECTIVE TISSUE DISEASE (DISORDER)
Clinical trials for INTERSTITIAL LUNG DISEASE DUE TO CONNECTIVE TISSUE DISEASE (DISORDER) explained in plain language.
Never miss a new study
Get alerted when new INTERSTITIAL LUNG DISEASE DUE TO CONNECTIVE TISSUE DISEASE (DISORDER) trials appear
Sign up with your email to follow new studies for INTERSTITIAL LUNG DISEASE DUE TO CONNECTIVE TISSUE DISEASE (DISORDER), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New inhaled therapy aims to slow lung scarring
Disease control Recruiting nowThis study tests an inhaled version of the drug pirfenidone (AP01) in 375 adults with progressive pulmonary fibrosis, a condition where lung scarring worsens over time. Participants receive either a high dose, low dose, or placebo twice daily for 52 weeks, alongside their usual c…
Matched conditions: INTERSTITIAL LUNG DISEASE DUE TO CONNECTIVE TISSUE DISEASE (DISORDER)
Phase: PHASE2 • Sponsor: Avalyn Pharma Inc. • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
New combo aims to shield scarred lungs from radiation damage
Disease control Recruiting nowThis study tests whether adding BIO 300 to standard chest radiation can prevent severe lung inflammation (pneumonitis) in people with early-stage non-small cell lung cancer who also have interstitial lung disease (lung scarring). About 25 adults will receive the combination and b…
Matched conditions: INTERSTITIAL LUNG DISEASE DUE TO CONNECTIVE TISSUE DISEASE (DISORDER)
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Apr 29, 2026 15:04 UTC
-
One-Stop shop for lung care: new trial aims to cut patient burden
Symptom relief Recruiting nowThis study tests a new way to organize follow-up care for people with interstitial lung disease (ILD). Instead of making several separate trips for tests, lab work, and doctor visits, the new approach bundles everything into one coordinated hospital visit. The goal is to reduce t…
Matched conditions: INTERSTITIAL LUNG DISEASE DUE TO CONNECTIVE TISSUE DISEASE (DISORDER)
Phase: NA • Sponsor: Hospital de Granollers • Aim: Symptom relief
Last updated May 17, 2026 03:09 UTC
-
New study aims to cut lung disease diagnosis time in half
Knowledge-focused Recruiting nowThis study tests whether bundling key tests (like CT scans and lung function tests) into a single, fast-tracked appointment can help people with suspected interstitial lung disease get a diagnosis sooner. About 92 adults will be randomly assigned to either the usual step-by-step …
Matched conditions: INTERSTITIAL LUNG DISEASE DUE TO CONNECTIVE TISSUE DISEASE (DISORDER)
Phase: NA • Sponsor: Hospital de Granollers • Aim: Knowledge-focused
Last updated May 14, 2026 12:02 UTC